BiomeSense, Inc. — Form D
BiomeSense, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-19. The offering totals $6.5M, of which $6.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-19
- Form: D
- Accession: 0001789915-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $6.2M
- Remaining: $345K
- Investors: 33
- Date of first sale: 2023-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-500187
Issuer
- Name: BiomeSense, Inc.
- CIK: 0001789915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2242 W. HARRISON ST, CHICAGO, IL, 60612
- Phone: 847-471-8663
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Parikshit Sharma | Director | Chicago, IL |
| Dylan Nichols | Director | Chicago, IL |
| Ashley Hartman | Director | Chicago, IL |
| Kevin Honaker | Director | Chicago, IL |
| Kevin Honaker | Executive Officer | Chicago, IL |
| Vanessa Rollings Giannis | Director | Chicago, IL |
| Andrew Bluestein | Director | Chicago, IL |
| Orhan Ertughrul | Director | Chicago, IL |
Other filings by this issuer (2)
More